CONFERENCE UPDATE : EULAR 2020
The latest guidelines on the pharmacological treatment of psoriatic arthritis
EULAR has published an updated version of the recommendations on treating psoriatic arthritis (PsA). The objective of the update is to include new PsA drugs.
On behalf of the EULAR PsA Management Taskforce, Dr. Laure Gossec, MD, Ph.D., a Professor of Rheumatology in Pitie-Salpetriere Hospital, Pierre and Marie Curie University (Paris 06 University), Paris, France, presented the new 2019 EULAR recommendations on the pharmacological treatment of PsA at the EULAR 2020 e-congress.
- Gossec L et al. The EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Annals of the Rheumatic Diseases 2020.
- Kerschbaumer A et al. Pharmacological treatment of psoriatic arthritis: systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritis. Ann Rheum Dis 2016
New interim guidelines for rheumatic and musculoskeletal diseases management in the context of COVID-19
During the EULAR 2020 e-congress, Dr. Robert Landewé, MD, Ph.D., Professor of the Amsterdam Rheumatology Center at the University of Amsterdam, and chair of the Department of Rheumatology at the Zuyderland Medical Center Heerlen, the Netherland, shared his perspective on the provisional EULAR